v3.26.1
Cash Equivalents and Marketable Securities
6 Months Ended
Jun. 30, 2026
Cash and Cash Equivalents [Abstract]  
Cash Equivalents and Marketable Securities

4. Cash Equivalents and Marketable Securities

Cash equivalents and marketable securities consisted of the following:

 

 

 

June 30, 2026

 

 

 

Amortized
Cost Basis

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

 

 

(in thousands)

 

Money market funds

 

$

44,695

 

 

$

 

 

$

 

 

$

44,695

 

Commercial paper

 

 

26,773

 

 

 

 

 

 

(12

)

 

 

26,761

 

Corporate debt securities

 

 

44,020

 

 

 

1

 

 

 

(16

)

 

 

44,005

 

Asset-backed securities

 

 

32,275

 

 

 

1

 

 

 

(15

)

 

 

32,261

 

U.S. government securities

 

 

14,967

 

 

 

 

 

 

(17

)

 

 

14,950

 

Total

 

 

162,730

 

 

 

2

 

 

 

(60

)

 

 

162,672

 

Less amounts classified as cash equivalents

 

 

(52,663

)

 

 

 

 

 

2

 

 

 

(52,661

)

Total marketable securities

 

$

110,067

 

 

$

2

 

 

$

(58

)

 

$

110,011

 

 

 

 

December 31, 2025

 

 

 

Amortized
Cost Basis

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

 

 

(in thousands)

 

Money market funds

 

$

51,333

 

 

$

 

 

$

 

 

$

51,333

 

Commercial paper

 

 

29,134

 

 

 

5

 

 

 

 

 

 

29,139

 

Corporate debt securities

 

 

16,950

 

 

 

2

 

 

 

 

 

 

16,952

 

Asset-backed securities

 

 

7,281

 

 

 

 

 

 

(1

)

 

 

7,280

 

U.S. government securities

 

 

29,914

 

 

 

13

 

 

 

 

 

 

29,927

 

Total

 

 

134,612

 

 

 

20

 

 

 

(1

)

 

 

134,631

 

Less amounts classified as cash equivalents

 

 

(51,333

)

 

 

 

 

 

 

 

 

(51,333

)

Total marketable securities

 

$

83,279

 

 

$

20

 

 

$

(1

)

 

$

83,298

 

No marketable securities had maturities of more than one year as of June 30, 2026 and December 31, 2025.

During the three and six months ended June 30, 2026, the Company did not record any other-than-temporary impairment charges on its available-for-sale securities. Based on the Company’s procedures under the expected credit loss model, including an assessment of unrealized losses on the portfolio after June 30, 2026, the Company concluded that the unrealized losses for its marketable securities were not attributable to credit and therefore an allowance for credit losses for these securities has not been recorded as of June 30, 2026. Also, based on the scheduled maturities of the investments, the Company was more likely than not to hold these investments for a period of time sufficient for a recovery of the Company’s cost basis.

The Company recognized no material gains or losses on its cash equivalents and marketable securities as of June 30, 2026 and as a result, the Company did not reclassify any amounts out of accumulated other comprehensive income (loss) for the period then ended.